IRIS Accounts Production v26.1.10.61 14586297 Board of Directors Board of Directors 1.2.25 31.1.26 31.1.26 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 C Ordinary 1.00000 D Ordinary 1.00000 E Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh145862972025-01-31145862972026-01-31145862972025-02-012026-01-31145862972024-01-31145862972024-02-012025-01-31145862972025-01-3114586297ns15:EnglandWales2025-02-012026-01-3114586297ns14:PoundSterling2025-02-012026-01-3114586297ns10:Director12025-02-012026-01-3114586297ns10:Director22025-02-012026-01-3114586297ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3114586297ns10:SmallEntities2025-02-012026-01-3114586297ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3114586297ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3114586297ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3114586297ns10:FullAccounts2025-02-012026-01-3114586297ns10:OrdinaryShareClass12025-02-012026-01-3114586297ns10:OrdinaryShareClass22025-02-012026-01-3114586297ns10:OrdinaryShareClass32025-02-012026-01-3114586297ns10:OrdinaryShareClass42025-02-012026-01-3114586297ns10:OrdinaryShareClass52025-02-012026-01-3114586297ns5:CurrentFinancialInstruments2026-01-3114586297ns5:CurrentFinancialInstruments2025-01-3114586297ns5:ShareCapital2026-01-3114586297ns5:ShareCapital2025-01-3114586297ns5:RetainedEarningsAccumulatedLosses2026-01-3114586297ns5:RetainedEarningsAccumulatedLosses2025-01-3114586297ns10:RegisteredOffice2025-02-012026-01-3114586297ns5:PlantMachinery2025-01-3114586297ns5:ComputerEquipment2025-01-3114586297ns5:PlantMachinery2025-02-012026-01-3114586297ns5:ComputerEquipment2025-02-012026-01-3114586297ns5:PlantMachinery2026-01-3114586297ns5:ComputerEquipment2026-01-3114586297ns5:PlantMachinery2025-01-3114586297ns5:ComputerEquipment2025-01-3114586297ns10:OrdinaryShareClass12026-01-3114586297ns10:OrdinaryShareClass22026-01-3114586297ns10:OrdinaryShareClass32026-01-3114586297ns10:OrdinaryShareClass42026-01-3114586297ns10:OrdinaryShareClass52026-01-31145862972ns10:Director22025-01-31145862972ns10:Director22024-01-31145862972ns10:Director22025-02-012026-01-31145862972ns10:Director22024-02-012025-01-31145862972ns10:Director22026-01-31145862972ns10:Director22025-01-3114586297ns10:Director112025-01-3114586297ns10:Director112024-01-3114586297ns10:Director112025-02-012026-01-3114586297ns10:Director112024-02-012025-01-3114586297ns10:Director112026-01-3114586297ns10:Director112025-01-31
REGISTERED NUMBER: 14586297 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st January 2026

for

Kent Colorectal And Laparoscopic Surgery
Limited

Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)






Contents of the Financial Statements
for the Year Ended 31st January 2026




Page

Balance Sheet 1

Notes to the Financial Statements 3


Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)

Balance Sheet
31st January 2026

31.1.26 31.1.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,050 1,488

CURRENT ASSETS
Debtors 5 7,715 7,639
Cash at bank 105,746 112,457
113,461 120,096
CREDITORS
Amounts falling due within one year 6 23,978 32,343
NET CURRENT ASSETS 89,483 87,753
TOTAL ASSETS LESS CURRENT
LIABILITIES

90,533

89,241

PROVISIONS FOR LIABILITIES 200 283
NET ASSETS 90,333 88,958

CAPITAL AND RESERVES
Called up share capital 7 203 203
Retained earnings 90,130 88,755
SHAREHOLDERS' FUNDS 90,333 88,958

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)

Balance Sheet - continued
31st January 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29th July 2026 and were signed on its behalf by:




Dr W Garrett - Director



Dr T Y Garrett - Director


Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)

Notes to the Financial Statements
for the Year Ended 31st January 2026

1. COMPANY INFORMATION

Kent Colorectal And Laparoscopic Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14586297

Registered office: Second Floor
The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1st February 2025
and 31st January 2026 1,314 699 2,013
DEPRECIATION
At 1st February 2025 350 175 525
Charge for year 263 175 438
At 31st January 2026 613 350 963
NET BOOK VALUE
At 31st January 2026 701 349 1,050
At 31st January 2025 964 524 1,488

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Trade debtors 7,715 7,639

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Tax 17,695 25,699
Social security and other taxes 908 -
Directors' current accounts 3,266 4,288
Accrued expenses 2,109 2,356
23,978 32,343

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.26 31.1.25
value: £    £   
100 A Ordinary £1 100 100
100 B Ordinary £1 100 100
1 C Ordinary £1 1 1
1 D Ordinary £1 1 1
1 E Ordinary £1 1 1
203 203

"The A, B, C, D and E shares rank Dr T Y Garrett in terms of dividends and capital distribution rights"

Kent Colorectal And Laparoscopic Surgery
Limited (Registered number: 14586297)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st January 2026 and 31st January 2025:

31.1.26 31.1.25
£    £   
Dr T Y Garrett
Balance outstanding at start of year (2,577 ) (2,577 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,577 ) (2,577 )

Dr W Garrett
Balance outstanding at start of year (1,711 ) (11 )
Amounts advanced 68,313 70,070
Amounts repaid (66,662 ) (71,770 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (60 ) (1,711 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROLLING PARTY

The controlling party is Dr W Garrett.